A: DAXXIFY™ is FDA-approved to help smooth moderate to severe lines between the brows. It is the only long-lasting frown line treatment powered by a peptide with results that last on average 6 months and up to 9 months for some. Produced by Revance Therapeutics, Daxxify is a revolutionary new product.
A: DAXXIFY™ is the only long-lasting frown line treatment powered by a peptide. Results last on average 6 months and up to 9 months for some. † • All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, BOTOX® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant. • DAXXIFY™ is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts. • †At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment. Between 3% and 5% of patients in clinical studies had no or minor frown lines 9 months after treatment. In other safety studies, between 5% and 17% of patients still had noticeable improvement 9 months later.
A: In short, no, and here’s why. Units are like fingerprints—they are a proprietary measurement of a treatment’s unique potency. Because of the differences in how treatments are formulated and tested, you cannot compare or convert Units between them, just like you cannot compare 2 fingerprints. A clearer way to understand dosing is to look at how many nanograms of active ingredient (botulinum toxin type A) a product has. Double the Units does not mean double the dose DAXXIFY™ Approved frown line dose: 40 Units Amount of active ingredient: 0.18 nanograms BOTOX® Cosmetic Approved frown line dose: 20 Units Amount of active ingredient: 0.18 nanograms DYSPORT® Approved frown line dose: 50 Units Amount of active ingredient: 0.27 nanograms As you can see, despite the number of Units, DAXXIFY™ isn’t 2x the dose of BOTOX® Cosmetic, nor is Dysport® 2.5x the dose of BOTOX® Cosmetic. Talk to your provider about DAXXIFY™ and your aesthetic goals.
A: No, not necessarily. The most common side effects observed in clinical trials occurred within one to two weeks after injection and lasted only a short while. This is consistent with other frown line treatments. DAXXIFY™ is well-studied, with no serious treatment-related side effects seen in large-scale clinical trials.
A: If you’re like most people, you probably get a frown line treatment around twice a year. But here’s the thing: conventional treatments only last 3–4 months. That means you may spend the next 2-3 months of the year with those frown lines staring back at you between treatments. That’s up to 4-6 months of total wear off time per year! • DAXXIFY™ is different. With those same 2 treatment visits, you can keep your frown lines smoother for a full year!§ • §At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment. • You may see results with DAXXIFY™ as early as the next day after treatment, and typically within two days.
A: DAXXIFY™ was studied in the largest-ever clinical study conducted for a frown line treatment and included more than 2,400 people across different ages and skin types. • There were no serious treatment-related side effects in clinical trials for DAXXIFY™. • The active ingredient in DAXXIFY™ is botulinum toxin type A, an ingredient that has been used in frown line treatments for more than 20 years. 96% of people treated with DAXXIFY™ were satisfied with their results† • †96% of patients reported they were satisfied on a 7-point scale when evaluated at 4 weeks in clinical studies.
A: DAXXIFY™ was studied in the largest-ever clinical study for a frown line treatment and included more than 2,800 people across different ages and skin types. Here are some things you should know about DAXXIFY™: • There were no serious treatment-related side effects • The active ingredient in DAXXIFY™ is botulinum toxin type A, an ingredient that has been used in frown line treatments for more than 20 years • 96% of people treated with DAXXIFY™ were satisfied with their results‡ • ‡96% of patients reported they were satisfied on a 7-point scale when evaluated at 4 weeks in clinical studies. • The safety and efficacy of DAXXIFY™ is well established, with more than 20 years of research. In fact, DAXXIFY™ has been studied in the largest ever phase 3 clinical trial program conducted for a frown line treatment and included more than 2,400 people across different ages and with different skin types. There were no notable differences in how DAXXIFY™ performed in clinical trial patients with varying skin types.
A: Ask your aesthetic provider for pre-treatment instructions prior to your DAXXIFY™ appointment. A list of common avoidances before treatment include, but are not limited to: Retin-A Blood thinners Muscle relaxants Fish or oils rich in omega 3 Allergy medication Topical steroids Sleep medications and supplements Aspirin St. John’s Wort Supplements containing Vitamin E Ibuprofen
A: All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, BOTOX® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant. DAXXIFY™ is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts.
A: DAXXIFY™ is FDA-approved to help smooth moderate to severe lines between the brows. It is the only long-lasting frown line treatment powered by a peptide with results that last on average 6 months and up to 9 months for some. Produced by Revance Therapeutics, Daxxify is a revolutionary new product.
A: DAXXIFY™ is the only long-lasting frown line treatment powered by a peptide. Results last on average 6 months and up to 9 months for some. † • All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, BOTOX® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant. • DAXXIFY™ is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts. • †At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment. Between 3% and 5% of patients in clinical studies had no or minor frown lines 9 months after treatment. In other safety studies, between 5% and 17% of patients still had noticeable improvement 9 months later.
A: In short, no, and here’s why. Units are like fingerprints—they are a proprietary measurement of a treatment’s unique potency. Because of the differences in how treatments are formulated and tested, you cannot compare or convert Units between them, just like you cannot compare 2 fingerprints. A clearer way to understand dosing is to look at how many nanograms of active ingredient (botulinum toxin type A) a product has. Double the Units does not mean double the dose DAXXIFY™ Approved frown line dose: 40 Units Amount of active ingredient: 0.18 nanograms BOTOX® Cosmetic Approved frown line dose: 20 Units Amount of active ingredient: 0.18 nanograms DYSPORT® Approved frown line dose: 50 Units Amount of active ingredient: 0.27 nanograms As you can see, despite the number of Units, DAXXIFY™ isn’t 2x the dose of BOTOX® Cosmetic, nor is Dysport® 2.5x the dose of BOTOX® Cosmetic. Talk to your provider about DAXXIFY™ and your aesthetic goals.
A: DAXXIFY™ was studied in the largest-ever clinical study for a frown line treatment and included more than 2,800 people across different ages and skin types. Here are some things you should know about DAXXIFY™: • There were no serious treatment-related side effects • The active ingredient in DAXXIFY™ is botulinum toxin type A, an ingredient that has been used in frown line treatments for more than 20 years • 96% of people treated with DAXXIFY™ were satisfied with their results‡ • ‡96% of patients reported they were satisfied on a 7-point scale when evaluated at 4 weeks in clinical studies. • The safety and efficacy of DAXXIFY™ is well established, with more than 20 years of research. In fact, DAXXIFY™ has been studied in the largest ever phase 3 clinical trial program conducted for a frown line treatment and included more than 2,400 people across different ages and with different skin types. There were no notable differences in how DAXXIFY™ performed in clinical trial patients with varying skin types.
A: No, not necessarily. The most common side effects observed in clinical trials occurred within one to two weeks after injection and lasted only a short while. This is consistent with other frown line treatments. DAXXIFY™ is well-studied, with no serious treatment-related side effects seen in large-scale clinical trials.
A: Ask your aesthetic provider for pre-treatment instructions prior to your DAXXIFY™ appointment. A list of common avoidances before treatment include, but are not limited to: Retin-A Blood thinners Muscle relaxants Fish or oils rich in omega 3 Allergy medication Topical steroids Sleep medications and supplements Aspirin St. John’s Wort Supplements containing Vitamin E Ibuprofen
A: If you’re like most people, you probably get a frown line treatment around twice a year. But here’s the thing: conventional treatments only last 3–4 months. That means you may spend the next 2-3 months of the year with those frown lines staring back at you between treatments. That’s up to 4-6 months of total wear off time per year! • DAXXIFY™ is different. With those same 2 treatment visits, you can keep your frown lines smoother for a full year!§ • §At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment. • You may see results with DAXXIFY™ as early as the next day after treatment, and typically within two days.
A: All frown line treatments require a special ingredient to stabilize botulinum toxin A, the protein responsible for helping smooth moderate to severe frown lines. For instance, BOTOX® Cosmetic uses human serum albumin (HSA), a blood product, as its stabilizer. Dysport®, another frown line treatment, uses HSA as a stabilizer and cow’s milk protein as a protectant. DAXXIFY™ is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts.
A: DAXXIFY™ was studied in the largest-ever clinical study conducted for a frown line treatment and included more than 2,400 people across different ages and skin types. • There were no serious treatment-related side effects in clinical trials for DAXXIFY™. • The active ingredient in DAXXIFY™ is botulinum toxin type A, an ingredient that has been used in frown line treatments for more than 20 years. 96% of people treated with DAXXIFY™ were satisfied with their results† • †96% of patients reported they were satisfied on a 7-point scale when evaluated at 4 weeks in clinical studies.
IMPORTANT SAFETY INFORMATION for DAXXIFY™ (daxibotulinumtoxinA-Ianm) injection:
APPROVED USE
DAXXIFY™ is a prescription medicine that is injected into muscles and used in adults to temporarily improve the look of moderate to severe frown lines between the eyebrows. DAXI-001723
Hagerstown, Hunt Valley, Knoxville, Prince Frederick, West Knoxville, Sevierville, and Virginia Beach.
Relax. We know everyone’s skin is a bit different. Once our knowledgeable medical staff, with years of cosmetic expertise, completes your initial skin consultation and analysis we will give you the answers that are right for your skin and recommend the products and services that will help you look and feel great. You’ll learn what products are best suited to your skin type and how you can best protect your skin from sun exposure, dryness and aging.
Error: Contact form not found.
